Loading...

Diffusion Pharmaceuticals Inc.

DFFN•NASDAQ
Healthcare
Biotechnology
$4.40
$0.41(10.28%)

Diffusion Pharmaceuticals Inc. (DFFN) Stock Overview

Explore Diffusion Pharmaceuticals Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B

Score: 66.7/100

Key Financials

Market Cap9M
P/E Ratio0.00
EPS (TTM)$-7.11
ROE196.74%
Fundamental Analysis

AI Price Forecasts

1 WeekN/A
1 MonthN/A
3 MonthsN/A
1 Year Target$2.42

DFFN Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Diffusion Pharmaceuticals Inc. (DFFN) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $2.42.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 0.00 and a market capitalization of 9M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Stats data is not available for DFFNStats details for DFFN are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Analyst Recommendations data is not available for DFFNAnalyst Recommendations details for DFFN are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Company Profile

Diffusion Pharmaceuticals Inc., a biopharmaceutical company, develops novel therapies that enhance the body's ability to deliver oxygen. Its lead product candidate is Trans Sodium Crocetinate that is developed to enhance the diffusion of oxygen to tissues, as well as to treat COVID-19 disease. Diffusion Pharmaceuticals Inc. was founded in 2001 and is based in Charlottesville, Virginia.

CEO

Robert J. Cobuzzi Jr.,

Employees

13

Headquarters

300 East Main Street, Charlottesville, VA

Founded

2008

Frequently Asked Questions

;